General description
INN
Vinblastine
Medicine type
Chemical agent
EML status history
First added in 1984
(TRS
722)
for
Unspecified malignant neoplasms of ill-defined or unspecified sites
Added in 2015
(TRS
994)
for
Hodgkin lymphoma
Added in 2015
(TRS
994)
for
Germ cell tumour of testis
Added in 2015
(TRS
994)
for
Kaposi sarcoma of unspecified primary site
Added in 2015
(TRS
994)
for
Other specified malignant neoplasms of the ovary
Removed in 2015
(TRS
994)
for
Unspecified malignant neoplasms of ill-defined or unspecified sites
Wikipedia
DrugBank
Recommendations
Section
Cytotoxic medicines
- Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate)